OCRA News
OCRA-Funded Research Yields Insight into Clear Cell Ovarian Cancers
(November 13, 2019) A study recently published in Nature Communications and led by OCRA grantee Dr. Rugang Zhang showed that the ARID1A protein plays a fundamental role in ensuring correct chromosome segregation when the cells divide…
OCRA’s STYLE LAB Shines a Spotlight on Ovarian Cancer
That’s a wrap on #OCRAStyleLab, and what an evening it was for ovarian cancer awareness! (November 6, 2019) Our sincere gratitude to our amazing hosts Maggie Gyllenhaal and Kate Mara, the fabulous En Vogue, media partner InStyle and all the…
IUD May Lower Risk of Developing Ovarian Cancer
(November 6, 2019) A recent research review conducted by a team at the University of Colorado Anschutz, and published this month by the American College of Obstetrics and Gynecology, found that use of an intrauterine device (IUD) was associated with…
OCRA-Funded Research Explores New Pathways for Understanding Metastases
(October 30) In an effort to further understand disease initiation and progression, OCRA grantee Dr…
Newk’s Eatery & Newk’s Cares Hit $1.4 Million Raised For Ovarian Cancer Research
(October 28, 2019) Newk’s Cares, the ovarian cancer awareness movement and national campaign founded by fast-casual restaurant Newk’s Eatery, has reached monumental heights! Celebrating its sixth year, Newk’s Cares raised more than $400,000 in…
Action Alert: Cosponsor Johanna’s Law Reauthorization (H.R. 4560)
We need your help to strengthen critical gynecologic cancer education and awareness programs. (October 16, 2019) Recently, Rep…
OCRA Hosts First Annual Hope Fashion Show in Dallas
(October 10, 2019) On September 19, fashion and inspiration for ovarian cancer cures hit the runway at OCRA’s first annual Hope Fashion Show in Dallas…
PARP Inhibitor and Chemotherapy Combination Improves Progression-Free Survival
(October 7, 2019) Published recently in the New England Journal of Medicine, a group of investigators led by OCRA Scientific Advisory Committee member Dr…
OCRA-Funded Research Elucidates New Immunotherapy Approach
(September 19, 2019) While harnessing the immune system has resulted in strong responses for a subset of cancer patients, the majority of patients have remained unresponsive to this approach…
Quiz: Test Your Ovarian Cancer Knowledge
It’s important for everyone to know the symptoms and risk factors for ovarian cancer…
OCRA-Funded Research Points to Surrounding Tissues for Further Study
(September 10, 2019) Ovarian clear-cell carcinoma is an aggressive form of ovarian cancer. Endometriosis is derived from the uterine endometrium and is a known risk factor for ovarian clear-cell carcinoma…
OCRA-Funded Research Moves Immunotherapy Forward
(September 5, 2019) OCRA funded investigator Dmitriy Zamarin, MD, PhD contributed to a study that provides an intriguing hypothesis that mutation in genes like SMARCA4 may improve tumor recognition by the immune system…